Insider Sale: President and CEO of $PBYI (PBYI) Sells 33,841 Shares

Quiver QuantitativeJan 3 19:15 ET

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why

Zacks Dec 27, 2024 09:30 ET

Puma Biotechnology's NERLYNX Added To NCCN Guidelines For HER2-Mutated Cervical Cancer; Approved As Second-Line Therapy For Recurrent Or Metastatic Disease Based On Phase II SUMMIT Trial Results

BenzingaDec 23, 2024 09:04 ET

Puma Biotechnology's NERLYNX Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer With a HER2 Mutation

BusinesswireDec 23, 2024 09:01 ET

Express News | Puma Biotechnology’s Nerlynx® Included in Nccn Clinical Practice Guidelines for the Treatment of Cervical Cancer With a Her2 Mutation

ReutersDec 23, 2024 09:01 ET

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireDec 4, 2024 17:15 ET